198 related articles for article (PubMed ID: 18640747)
1. [Chronic-granulomatous disease].
Stasia MJ; Cathebras P; Lutz MF; Durieu I
Rev Med Interne; 2009 Mar; 30(3):221-32. PubMed ID: 18640747
[TBL] [Abstract][Full Text] [Related]
2. Chronic granulomatous disease: Clinical, molecular, and therapeutic aspects.
Chiriaco M; Salfa I; Di Matteo G; Rossi P; Finocchi A
Pediatr Allergy Immunol; 2016 May; 27(3):242-53. PubMed ID: 26680691
[TBL] [Abstract][Full Text] [Related]
3. Clinical, functional, and genetic characterization of chronic granulomatous disease in 89 Turkish patients.
Köker MY; Camcıoğlu Y; van Leeuwen K; Kılıç SŞ; Barlan I; Yılmaz M; Metin A; de Boer M; Avcılar H; Patıroğlu T; Yıldıran A; Yeğin O; Tezcan I; Sanal Ö; Roos D
J Allergy Clin Immunol; 2013 Nov; 132(5):1156-1163.e5. PubMed ID: 23910690
[TBL] [Abstract][Full Text] [Related]
4. The search for a genetic defect in Polish patients with chronic granulomatous disease.
Jurkowska M; Kurenko-Deptuch M; Bal J; Roos D
Arch Immunol Ther Exp (Warsz); 2004; 52(6):441-6. PubMed ID: 15577746
[TBL] [Abstract][Full Text] [Related]
5. [Molecular aspects of chronic granulomatous disease. "the NADPH oxidase complex"].
Morel F
Bull Acad Natl Med; 2007 Feb; 191(2):377-90; discussion 390-2. PubMed ID: 17969555
[TBL] [Abstract][Full Text] [Related]
6. Functional Restoration of gp91phox-Oxidase Activity by BAC Transgenesis and Gene Targeting in X-linked Chronic Granulomatous Disease iPSCs.
Laugsch M; Rostovskaya M; Velychko S; Richter C; Zimmer A; Klink B; Schröck E; Haase M; Neumann K; Thieme S; Roesler J; Brenner S; Anastassiadis K
Mol Ther; 2016 Apr; 24(4):812-22. PubMed ID: 26316390
[TBL] [Abstract][Full Text] [Related]
7. Chronic granulomatous disease: Clinical, functional, molecular, and genetic studies. The Israeli experience with 84 patients.
Wolach B; Gavrieli R; de Boer M; van Leeuwen K; Berger-Achituv S; Stauber T; Ben Ari J; Rottem M; Schlesinger Y; Grisaru-Soen G; Abuzaitoun O; Marcus N; Zion Garty B; Broides A; Levy J; Stepansky P; Etzioni A; Somech R; Roos D
Am J Hematol; 2017 Jan; 92(1):28-36. PubMed ID: 27701760
[TBL] [Abstract][Full Text] [Related]
8. Genetic and biochemical background of chronic granulomatous disease.
Jurkowska M; Bernatowska E; Bal J
Arch Immunol Ther Exp (Warsz); 2004; 52(2):113-20. PubMed ID: 15179325
[TBL] [Abstract][Full Text] [Related]
9. Functional analysis of two-amino acid substitutions in gp91 phox in a patient with X-linked flavocytochrome b558-positive chronic granulomatous disease by means of transgenic PLB-985 cells.
Bionda C; Li XJ; van Bruggen R; Eppink M; Roos D; Morel F; Stasia MJ
Hum Genet; 2004 Oct; 115(5):418-27. PubMed ID: 15338276
[TBL] [Abstract][Full Text] [Related]
10. X-linked chronic granulomatous disease: first report of mutations in patients of Argentina.
Barese C; Copelli S; Zandomeni R; Oleastro M; Zelazko M; Rivas EM
J Pediatr Hematol Oncol; 2004 Oct; 26(10):656-60. PubMed ID: 15454837
[TBL] [Abstract][Full Text] [Related]
11. A novel missense mutation in the NADPH binding domain of CYBB abolishes the NADPH oxidase activity in a male patient with increased susceptibility to infections.
Khan TA; Kalsoom K; Iqbal A; Asif H; Rahman H; Farooq SO; Naveed H; Nasir U; Amin MU; Hussain M; Tipu HN; Florea A
Microb Pathog; 2016 Nov; 100():163-169. PubMed ID: 27666509
[TBL] [Abstract][Full Text] [Related]
12. [The NADPH-oxidase complex in chronic granulomatous disease: preliminary description of a cluster in Mérida-Venezuela].
Salmen S; Berrueta L; Heyworth P; Borges L; Hernández M; Muñoz J
Invest Clin; 1999 Dec; 40(4):277-300. PubMed ID: 10666954
[TBL] [Abstract][Full Text] [Related]
13. A Novel CYBB Mutation in Chronic Granulomatous Disease in Iran.
Tajik S; Badalzadeh M; Fazlollahi MR; Houshmand M; Zandieh F; Khandan S; Pourpak Z
Iran J Allergy Asthma Immunol; 2016 Oct; 15(5):426-429. PubMed ID: 27917630
[TBL] [Abstract][Full Text] [Related]
14. Chronic Granulomatous Disease.
Rawat A; Bhattad S; Singh S
Indian J Pediatr; 2016 Apr; 83(4):345-53. PubMed ID: 26865172
[TBL] [Abstract][Full Text] [Related]
15. Genetic analysis of CYBB gene in 26 korean families with X-linked chronic granulomatous disease.
Ko SH; Rhim JW; Shin KS; Hahn YS; Lee SY; Kim JG
Immunol Invest; 2014; 43(6):585-94. PubMed ID: 24999735
[TBL] [Abstract][Full Text] [Related]
16. Lentivirus-mediated gene transfer of gp91phox corrects chronic granulomatous disease (CGD) phenotype in human X-CGD cells.
Saulnier SO; Steinhoff D; Dinauer MC; Zufferey R; Trono D; Seger RA; Hossle JP
J Gene Med; 2000; 2(5):317-25. PubMed ID: 11045425
[TBL] [Abstract][Full Text] [Related]
17. Genetical analysis of all Danish patients diagnosed with chronic granulomatous disease.
Jakobsen MA; Katzenstein TL; Valerius NH; Roos D; Fisker N; Mogensen TH; Jensen PØ; Barington T
Scand J Immunol; 2012 Nov; 76(5):505-11. PubMed ID: 22924696
[TBL] [Abstract][Full Text] [Related]
18. X-linked chronic granulomatous disease (CGD) caused by an intra-exonic splice mutation (CYBB exon 3, c.262G->A) is mimicking juvenile sarcoidosis.
Brunner J; Dockter G; Rösen-Wolff A; Roesler J
Clin Exp Rheumatol; 2007; 25(2):336-8. PubMed ID: 17543165
[TBL] [Abstract][Full Text] [Related]
19. CRISPR-Mediated Knockout of Cybb in NSG Mice Establishes a Model of Chronic Granulomatous Disease for Human Stem-Cell Gene Therapy Transplants.
Sweeney CL; Choi U; Liu C; Koontz S; Ha SK; Malech HL
Hum Gene Ther; 2017 Jul; 28(7):565-575. PubMed ID: 28264583
[TBL] [Abstract][Full Text] [Related]
20. Molecular characterization of a novel splice site mutation within the CYBB gene leading to X-linked chronic granulomatous disease.
Barese CN; Copelli SB; De Matteo E; Zandomeni R; Salgueiro F; Di Giovanni D; Heyworth P; Rivas EM
Pediatr Blood Cancer; 2005 Apr; 44(4):420-2. PubMed ID: 15468310
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
